CRL
NYSE · Life Sciences Tools & Services
Charles River Laboratories
$337.52
+24.50 (+7.83%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
-78.9% upside
Low Target
$57.45
Average Target
$71.21
High Target
$105.86
Current Price
$337.52
Current
$337.52
$337.52
Target
$71.21
$71.21
$57.45
$71.21 avg
$105.86
Scenario Analysis
Bear Case
$57.45
-83.0%
Low target
Base Case
$71.21
-78.9%
Avg target
Bull Case
$105.86
+-68.6%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$379.63
-11.1% from high
52-Week Low
$146.20
+130.9% from low
50-Day SMA
$305.60
+10.4% vs SMA
200-Day SMA
$224.56
+50.3% vs SMA
RSI (14)
59.3
Neutral
Target vs 52W High
$71.21
-81.2% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 35 | 86% | $369.21 | -46.9% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -31.3% |
| A | Buy | 29 | 72% | $64.69 | -63.0% |
| IQV | Strong Buy | 27 | 85% | $82.96 | -69.5% |
| WAT | Buy | 30 | 70% | $189.60 | -58.6% |
| MTD | Hold | 19 | 47% | $170.43 | -90.1% |
| ILMN | Buy | 28 | 57% | $169.36 | -20.5% |
| WST | Strong Buy | 22 | 95% | $136.24 | -65.9% |